Care considerations for glucocorticoid (steroid) initiation and use for patients with Duchenne muscular dystrophy
Care considerations for glucocorticoid (steroid) initiation and use for patients with Duchenne muscular dystrophy
CRH: corticotropin-releasing hormone; ACTH: adrenocorticotropic hormone; HPA: hypothalamic-pituitary-adrenal; IM: intramuscular; IV: intravenous. * The PJ Nicholoff tapering protocol is available online.
Original figure modified for this publication. From: Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 2018; 17:251. Illustration used with the permission of Elsevier Inc. All rights reserved.
Graphic 116911 Version 2.0
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟